Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients - Brooks, James D.; Wei, Wei; Hawley, Sarah; Auman, Heidi; Newcomb, Lisa; Boyer, Hilary; Fazli, Ladan; Simko, Jeff; Hurtado-Coll, Antonio; Troyer, Dean A.; Carroll, Peter R.; Gleave, Martin; et al. (PloS one, 2015)
Keywords: Adult; Aged; Aged, 80 and over; Biomarkers; Biomarkers, Tumor - metabolism; Cancer; Cancer surgery; Cancer therapies; Carrier Proteins - metabolism; Cohort Studies; Correlation analysis; Deoxyribonucleic acid; DNA; DNA microarrays; Gene expression; Gene Expression Regulation, Neoplastic; Hospitals; Humans; Immunohistochemistry; Male; Medical prognosis; Medical research; Middle Aged; Mortality; Multivariate analysis; Overexpression; Pathology; Patients; Prostate; Prostate cancer; Prostatectomy; Prostatic Neoplasms - metabolism; Prostatic Neoplasms - pathology; Prostatic Neoplasms - surgery; Proteins; Regression analysis; Staining; Staining and Labeling; Survival; Trans-Activators - metabolism; Transcriptional Regulator ERG; Treatment Outcome; Trypsin Inhibitor, Kazal Pancreatic; Tumors; Urological surgery; Urology